HDAC6 and amyotrophic lateral sclerosis: HDAC6 inhibition using Tubastatin A restored axonal transport deficits in motor neurons derived from both FUS-ALS (Guo et al., 2017) and TDP-43-ALS patients (Fazal et al., 2021).